| ![](/p.gif) |
![](/p.gif) |
| Artikel-Nr.: 5667A-9783319870830 Herst.-Nr.: 9783319870830 EAN/GTIN: 9783319870830 |
| |
|
| ![](/p.gif) | ![](/p.gif) |
![](/p.gif) | While non-cystic fibrosis bronchiectasis was formerly regarded as an "orphan" disease, international data reveal an increase in its prevalence in recent years. Accordingly, there has been renewed interest in the disease, resulting in more clinical research and the development of new treatments. The impact of bronchiectasis on healthcare systems is substantial and it has a clear attributable mortality. In covering all aspects of the disease, this book will be of interest to respiratory, internal medicine, and infectious disease fellows as well as specialists, final-year medical students, nurses and physiotherapists. The authors are leading experts and chairs of the steering committee of EMBARC, the first truly international bronchiectasis network. Weitere Informationen: ![](/p.gif) | ![](/p.gif) | Author: | James Chalmers; Eva Polverino; Stefano Aliberti | Verlag: | Springer International Publishing | Sprache: | eng |
|
| ![](/p.gif) | ![](/p.gif) |
![](/p.gif) | | ![](/p.gif) | ![](/p.gif) |
![](/p.gif) | Weitere Suchbegriffe: Airway disease, Microbiology, Inhaled antibiotics, Chronic infection, Recurrent respiratory infections, Oral antibiotics, Pulmonary rehabilitation, Predisposing factors, Airway clearance, Nursing management, infectious diseases |
| ![](/p.gif) | ![](/p.gif) |
| |